Insider selling is not extreme, but the cluster near a debt facility expansion warrants monitoring. Watch for any upcoming disclosure on clinical data or additional financing that might have motivated these sales. If selling continues, it could pressure shares near term.
Price Chart
Executive Summary
Three Dyne Therapeutics insiders sold a combined $5.02M in shares over a 6-day window, led by Director Rhodes ($4.9M). CFO Lucera sold a small amount ($48K). The sales follow a recent $50M borrowing under an expanded $400M Hercules debt facility (8-K on 6/17). Total selling represents ~0.14% of market cap, a modest amount that is not alarming given the pre-revenue biotech context.
Key Financial Metrics
Key Facts
- Insider cluster: 3 insiders sold 5 trades totaling $5.02M from June 23-29.
- Director Jason Rhodes sold $5.0M (bulk of sales); CFO Erick Lucera sold $48K.
- Sales follow June 17 debt facility expansion ($50M draw, $400M total capacity).
- Total sales represent ~0.14% of DYN's $3.5B market cap.
Financial Impact
Insider sales of $5.02M, modest relative to $3.5B market cap.
Risk Factors
- Continued insider selling could signal lack of confidence or pre-arranged plans.
- Debt facility increases leverage and secured IP collateral; adverse clinical data could trigger covenant issues.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-DYN-1782860743423 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 17, 2026 6w ago | Insider Cluster | $26.15 $17.90 | ▲ +31.55% | ▲ +29.57% | $15.20 (+41.87%) |
Aug 14, 2026 6w ago | 144 | $26.15 $18.52 | ▼ −29.18% | ▼ −27.65% | $15.20 (−41.87%) |
Aug 13, 2026 7w ago | 144 | $25.70 $18.52 | ▲ +27.94% | ▲ +25.95% | $15.20 (+40.86%) |
Aug 13, 2026 7w ago | 144 | $25.70 $18.52 | ▼ −27.94% | ▼ −25.95% | $15.20 (−40.86%) |
Aug 13, 2026 7w ago | 144 | $25.70 $18.52 | ▼ −27.94% | ▼ −25.95% | $15.20 (−40.86%) |
Jul 29, 2026 9w ago | Press Release | $25.73 $26.09 | ▲ +1.40% | ▼ −2.57% | $15.20 (−40.92%) |
Jul 22, 2026 10w ago | Press Release | $23.21 $26.78 | ▼ −15.38% | ▼ −12.48% | $15.20 (+34.51%) |
Jul 20, 2026 10w ago | 8-K | $23.45 $26.15 | ▲ +11.51% | ▲ +7.39% | $15.20 (−35.18%) |
Jun 30, 2026 13w ago | Insider Cluster | $21.79 $25.10 | ▲ +15.19% | ▲ +17.38% | $15.20 (−30.24%) |
Jun 29, 2026 13w ago | 144 | $22.21 $25.63 | ▼ −15.40% | ▼ −16.43% | $15.20 (+31.56%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access